Dr. Rahul Sharma is an internationally recognized molecular biologist whose groundbreaking work has advanced the fields of infectious disease diagnostics, precision metagenomics, and translational genomics. As Chief Scientific Officer of OSPRI and former director of several federally supported molecular laboratories, he has led the design and clinical validation of molecular assays now in use across healthcare systems worldwide. Dr. Sharma holds multiple patents in molecular diagnostics and has authored numerous peer-reviewed publications, with his research cited by the CDC, HHS, and featured in major outlets including The New York Times, Wall Street Journal, and CNN. A certified CAP inspector and expert in CLIA, CMS, and FDA-IVD regulatory pathways, he is widely regarded as a national authority on lab-developed test compliance and innovation. With more than two decades of global scientific leadership, Dr. Sharma continues to shape the future of molecular diagnostics at the intersection of science, regulation, and clinical impact. At OSPRI, Dr. Sharma leads scientific strategy, regulatory validation, and the development of next-generation molecular testing platforms.

Leadership